CTL Line Characteristics
Patient ID . | CD3+/CD4+ (%) . | CD3+/CD8+ (%) . | TCRαβ1/CD3+ (%) . | TCRγδ1/CD3+ (%) . | CD56+/CD3+ (%) . | LMP2 tetramer positivity . | HLA type . |
|---|---|---|---|---|---|---|---|
| 1 | 10 | 91 | 99 | 1.3 | 5.5 | not tested | A3;11/B27;51 |
| 2 | 3 | 94 | 85 | 0.3 | 4 | not tested | A2;3/B44;62 |
| 3 | 15 | 56 | 72 | 1.9 | 25 | yes | A2;3/B18;35 |
| 4 | 1.5 | 85 | 96 | 0.9 | 9 | not tested | A3/B7;40(61) |
| 5 | 17 | 84 | 61 | 34 | 15 | not tested | A3;24/B7 |
| 6 | 1.2 | 98 | 98 | 1.2 | 0.7 | yes | A2;3/B7;51 |
| 7 | 15 | 58 | 48 | 45 | 16 | yes | A2;32/B18;71 |
| 8 | 0.1 | 99 | 99 | 0.1 | 29 | yes | A2;3/B7;18 |
| 9 | 3 | 78 | 51 | 57 | 5 | no | A31;68/B35;39 |
| 10 | 38 | 63 | 90 | 7 | 34 | yes | A1;24/B18;53 |
| 11 | 0.6 | 95 | 95 | 12 | 1.8 | yes | A1;68/B35;81 |
| 12 | 1 | 98 | 96 | 2.5 | 0.7 | yes | A11;29/B7;40(61) |
| 13 | 49 | 39 | 86 | 15 | 0.1 | yes | A1;24/B35;61 |
| 14 | 24 | 54 | 83 | 15 | 0.8 | no | A2;26/B44;50 |
Patient ID . | CD3+/CD4+ (%) . | CD3+/CD8+ (%) . | TCRαβ1/CD3+ (%) . | TCRγδ1/CD3+ (%) . | CD56+/CD3+ (%) . | LMP2 tetramer positivity . | HLA type . |
|---|---|---|---|---|---|---|---|
| 1 | 10 | 91 | 99 | 1.3 | 5.5 | not tested | A3;11/B27;51 |
| 2 | 3 | 94 | 85 | 0.3 | 4 | not tested | A2;3/B44;62 |
| 3 | 15 | 56 | 72 | 1.9 | 25 | yes | A2;3/B18;35 |
| 4 | 1.5 | 85 | 96 | 0.9 | 9 | not tested | A3/B7;40(61) |
| 5 | 17 | 84 | 61 | 34 | 15 | not tested | A3;24/B7 |
| 6 | 1.2 | 98 | 98 | 1.2 | 0.7 | yes | A2;3/B7;51 |
| 7 | 15 | 58 | 48 | 45 | 16 | yes | A2;32/B18;71 |
| 8 | 0.1 | 99 | 99 | 0.1 | 29 | yes | A2;3/B7;18 |
| 9 | 3 | 78 | 51 | 57 | 5 | no | A31;68/B35;39 |
| 10 | 38 | 63 | 90 | 7 | 34 | yes | A1;24/B18;53 |
| 11 | 0.6 | 95 | 95 | 12 | 1.8 | yes | A1;68/B35;81 |
| 12 | 1 | 98 | 96 | 2.5 | 0.7 | yes | A11;29/B7;40(61) |
| 13 | 49 | 39 | 86 | 15 | 0.1 | yes | A1;24/B35;61 |
| 14 | 24 | 54 | 83 | 15 | 0.8 | no | A2;26/B44;50 |
HLA specificity of the tetramer is highlighted in bold.